Drugs / BikDD Nanoparticle
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00968604 | Mar 2015 → Mar 2017 | malignant pancreatic neoplasm | M.D. Anderson Cancer Center | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BikDD Nanoparticle | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00968604 ↗ |
| Route | Intravenous | “you will receive BikDD nanoparticle through a needle in your vein over about 10 minutes.” NCT00968604 ↗ |